Overall, I understand the need for this pilot study to determine feasibility, because this may be a very difficult study to conduct. For example, there is a strong opinion among healthcare professionals, that cancer surgery is a contraindication to cell salvage. The authors cite 4 or 5 studies suggesting that salvage is safe, however many clinicians remain skeptical, nonetheless. This is actually a good reason to do feasibility, because patients who read on the internet will also be very skeptical, and there will be many of these patients who will be reading on the internet, guaranteed.
Another concern I have is patients getting different variations of treatment. For example, in the salvage group they could receive: 1) no blood at all, 2) allogeneic blood only, 3) salvaged blood only, or 4) both salvaged and allogeneic blood. This is because not all salvaged cases yield enough shed blood to be processed and returned to the patient. And not all salvaged blood is enough to satisfy their needs, and the patients often need more than salvaged blood alone. In the allogeneic group, they could either receive: 1) no blood at all, or 2) allogeneic blood. I am afraid that with 60 patients, with 30 in each group, that these scenarios will yield a lot of variation in treatments, with very small "n"s in the individual groups. I do not see the authors plan to analyze the data according to assigned treatment or received treatment, or both ways.
Page 7 -LM 56 -On the telephone follow up for adverse events, what are these adverse events? I don't see what events are being assessed.
Page 9 -LM 4 -I think the randomization should be stratified on primary surgery vs. post chemotherapy surgery. This way there will be less chance of confounding by this factor.
Page 10 -The investigators should incorporate some form of Hb trigger into the protocol for transfusion, for allogeneic blood. Even if it is just a guideline and not absolute. Otherwise the use of banked blood could be different in the two groups due to treatment bias.
Page 10-11 -What about partially filled cell salvage bowls? Will they be processed and returned to the patients? This is controversial due to incomplete washing and potential for lower quality salvaged product. What size bowls will be chosen and by what criteria? A smaller bowl will ensure more complete washing and more yield back to the patients. 
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GENERAL COMMENTS
As mentioned in the attached document. In addition: 5. They can be a little more elaborate about their research ethics approval. 7. Unfortunately, I am not an expert in statistics. It is appropriate as per my knowledge. I would however rely on the statistician employed by the journal to look at the statistics more critically. 8. We have suggested some references to be changed, in the accompanying pdf document.
-The reviewer provided a marked copy with additional comments. Please contact the publisher for full details.
